Christos S. Mantzoros - Search Results

Year	Number of Results
2002	5
2003	13
2004	18
2005	12
2006	15
2007	26
2008	19
2009	25
2010	25
2011	41
2012	24
2013	34
2014	49
2015	41
2016	33
2017	24
2018	29
2019	32
2020	33
2021	32
2022	44
2023	37
2024	15

1

Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies.

Kokkorakis M, Muzurović E, Volčanšek Š, Chakhtoura M, Hill MA, Mikhailidis DP, Mantzoros CS. Kokkorakis M, et al. Among authors: mantzoros cs. Pharmacol Rev. 2024 May 2;76(3):454-499. doi: 10.1124/pharmrev.123.001087. Pharmacol Rev. 2024. PMID: 38697855 Review.

2

Pioglitazone does not enhance exogenous glucose oxidation or metabolic clearance rate during aerobic exercise in men under acute high altitude exposure.

Margolis LM, Wilson M, Drummer DJ, Carrigan CT, Murphy NE, Allen JT, Dawson MA, Mantzoros CS, Young AJ, Pasiakos SM. Margolis LM, et al. Among authors: mantzoros cs. Am J Physiol Regul Integr Comp Physiol. 2024 Apr 29. doi: 10.1152/ajpregu.00064.2024. Online ahead of print. Am J Physiol Regul Integr Comp Physiol. 2024. PMID: 38682243

3

Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges.

Kokkorakis M, Boutari C, Hill MA, Kotsis V, Loomba R, Sanyal AJ, Mantzoros CS. Kokkorakis M, et al. Among authors: mantzoros cs. Metabolism. 2024 May;154:155835. doi: 10.1016/j.metabol.2024.155835. Epub 2024 Mar 19. Metabolism. 2024. PMID: 38508373 No abstract available.

4

Relative Energy Deficiency in sport (REDs): Endocrine manifestations, pathophysiology and treatments.

Angelidi AM, Stefanakis K, Chou SH, Valenzuela-Vallejo L, Dipla K, Boutari C, Ntoskas K, Tokmakidis P, Kokkinos A, Goulis DG, Papadaki HA, Mantzoros CS. Angelidi AM, et al. Among authors: mantzoros cs. Endocr Rev. 2024 Mar 15:bnae011. doi: 10.1210/endrev/bnae011. Online ahead of print. Endocr Rev. 2024. PMID: 38488566

5

The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials.

Haber R, Zarzour F, Ghezzawi M, Saadeh N, Bacha DS, Al Jebbawi L, Chakhtoura M, Mantzoros CS. Haber R, et al. Among authors: mantzoros cs. Diabetes Obes Metab. 2024 May;26(5):1850-1867. doi: 10.1111/dom.15501. Epub 2024 Mar 11. Diabetes Obes Metab. 2024. PMID: 38468148

6

Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: The ATTICA cohort study (2002-2022).

Kouvari M, Chrysohoou C, Damigou E, Barkas F, Kravvariti E, Liberopoulos E, Tsioufis C, Sfikakis PP, Pitsavos C, Panagiotakos D, Mantzoros CS; ATTICA Study group. Kouvari M, et al. Among authors: mantzoros cs. Clin Nutr. 2024 Mar;43(3):900-908. doi: 10.1016/j.clnu.2024.02.006. Epub 2024 Feb 10. Clin Nutr. 2024. PMID: 38387279

7

Robust use of phenotypic heterogeneity at drug target genes for mechanistic insights: Application of cis-multivariable Mendelian randomization to GLP1R gene region.

Patel A, Gill D, Shungin D, Mantzoros CS, Knudsen LB, Bowden J, Burgess S. Patel A, et al. Among authors: mantzoros cs. Genet Epidemiol. 2024 Feb 20. doi: 10.1002/gepi.22551. Online ahead of print. Genet Epidemiol. 2024. PMID: 38379245

8

Genetic investigation into the broad health implications of caffeine: evidence from phenome-wide, proteome-wide and metabolome-wide Mendelian randomization.

Zagkos L, Cronjé HT, Woolf B, de La Harpe R, Burgess S, Mantzoros CS, Elliott P, Yuan S, Larsson SC, Tzoulaki I, Gill D. Zagkos L, et al. Among authors: mantzoros cs. BMC Med. 2024 Feb 20;22(1):81. doi: 10.1186/s12916-024-03298-y. BMC Med. 2024. PMID: 38378567 Free PMC article.

9

Thyroid function, adipokines and mitokines in metabolic dysfunction-associated steatohepatitis: A multi-centre biopsy-based observational study.

Kouvari M, Valenzuela-Vallejo L, Axarloglou E, Verrastro O, Papatheodoridis G, Mingrone G, George J, Mantzoros CS. Kouvari M, et al. Among authors: mantzoros cs. Liver Int. 2024 Mar;44(3):848-864. doi: 10.1111/liv.15847. Epub 2024 Jan 23. Liver Int. 2024. PMID: 38263703

10

Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study.

Kokkinos A, Tsilingiris D, Simati S, Stefanakis K, Angelidi AM, Tentolouris N, Anastasiou IA, Connelly MA, Alexandrou A, Mantzoros CS. Kokkinos A, et al. Among authors: mantzoros cs. Metabolism. 2024 Mar;152:155773. doi: 10.1016/j.metabol.2023.155773. Epub 2024 Jan 3. Metabolism. 2024. PMID: 38181882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

508 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

508 results

Results by year